Australia markets open in 1 hour 17 minutes

Telesis Bio, Inc. (TBIO)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
4.2700-0.2400 (-5.32%)
At close: 04:00PM EDT
4.2000 -0.07 (-1.64%)
After hours: 06:41PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
24,633
27,509
27,435
11,043
6,576
Cost of revenue
9,748
10,559
11,840
6,744
2,951
Gross profit
14,885
16,950
15,595
4,299
3,625
Operating expenses
Research development
15,300
17,496
23,460
14,466
8,925
Selling general and administrative
32,285
34,604
38,620
25,207
11,061
Total operating expenses
47,585
52,100
62,080
39,673
19,986
Operating income or loss
-32,700
-35,150
-46,485
-35,374
-16,361
Interest expense
2,683
3,105
1,955
1,369
690
Total other income/expenses net
-11,417
-11,188
-745
-2,201
-954
Income before tax
-45,219
-47,700
-48,447
-38,944
-18,005
Income tax expense
23
24
24
14
5
Income from continuing operations
-45,242
-47,724
-48,471
-38,958
-18,010
Net income
-45,242
-47,724
-48,471
-38,958
-18,010
Net income available to common shareholders
-47,127
-49,024
-48,471
-38,958
-18,010
Basic EPS
-1.31
-29.52
-29.70
-38.52
-15.07
Diluted EPS
-1.31
-29.52
-29.70
-38.52
-15.07
Basic average shares
29,738
1,658
1,637
1,012
1,195
Diluted average shares
29,738
1,658
1,637
1,012
1,195